Gliomas Unknown Status Phase 2 Trials for Bevacizumab (DB00112)
Also known as: Glioma / [M]Glioma NOS
| Indication | Status | Phase |
|---|---|---|
| DBCOND0032593 (Gliomas) | Unknown Status | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00660621 | A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma | Treatment |